Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Conditions

Healthy

Interventions

DRUG

BHT low

DRUG

BHT medium

DRUG

BHT high

DRUG

BI 54903 XX low

DRUG

BI 54903 XX medium 1

DRUG

BI 54903 XX medium 2

DRUG

BI 54903 XX high

DRUG

Ciclesonide